from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1028c/kdpD

LFCtreatmentdescriptionclass of inhibitor

-0.519

Amikacinug/mL Amikacintranslation

0.119

Cap5-10ug/mL Capreomycintranslation

0.066

Rox10-50 ug/mL Roxithromycintranslation

-0.199

SM2-5 ug/mL Streptomycintranslation

-1.243

Tet5-10 ug/mL Tetracyclinetranslation

0.618

Rif0.2-5ug/mL Rifampicintranscription

-0.735

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.411

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.043

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

1.256

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.253

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.514

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.219

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.702

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.731

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.559

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.420

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.465

Nigericin50 uM Nigericinrespiration

0.948

TRC10-150 ug/mL Triclosanrespiration

0.826

TRZ10-25 ug/mL Thioridazinerespiration

-0.510

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.967

menadione6-10 ug/mL Menadionerespiration

-0.282

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.421

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.061

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.153

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.275

NRP_1Non-replicating persistence stage 1dosRassociated

-0.363

Amp0.2mg/mL AmpicillincellWall

-0.537

Cephalexin20-100 ug/mL CephalexincellWall

-1.263

Cerulenin0.32-5 ug/mL CerulenincellWall

0.273

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.470

EMB10-20 ug/mL EthambutolcellWall

-0.649

Eta12-40 ug/mL EthionamidecellWall

-0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.806

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.412

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.454

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.064

BZA0.12 mg/mL BenzamidearomaticAmides

0.689

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.379

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.109

H2O24 mM hydrogen peroxideDNAdamaging

0.546

Levo10 ug/mL LevofloxacinDNAdamaging

-0.101

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.376

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.076

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.144

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.246

Antimycin12.5-50 ug/mL Antimycin A?

-1.813

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.043

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.566

PA8240.2-2 ug/mL PA-824?

0.480

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.025

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.718

Verapamil50 uM Verapamil?

-0.769

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.357

methoxatin10-20 ug/mL Methoxatin?